𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model

✍ Scribed by Joseph R. Drago; Thomas Worgul; M. Eric Gershwin


Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
798 KB
Volume
16
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This report presents the experience with single and combination chemotherapy in the Noble rat prostatic adenocarcinoma model. The best single agent in treatment of these tumors is cyclophosphamide, the best combination was triple drug therapy cyclophosphamide, cis‐plati‐num, and adriamycin. This report examines the effect of the various chemotherapeutic regimens on tumor volume, number of metastasis, and complete tumor regression.


πŸ“œ SIMILAR VOLUMES


Nb rat prostate adenocarcinoma model and
✍ Joseph R. Drago; Patti Weed; Anne Fralisch πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 230 KB

## Abstract In this preliminary report, evaluation of nontraditional agents has been used to evaluate control of metastasis. This androgen‐sensitive rat prostic adenocarcinoma has been subject to the treatments of heparin, indocin, and castration, as well as combinations of castration, heparin, ind

Adriamycin-vitamin E combination therapy
✍ John A. Nesbitt; Jeffery Smith; Gladstone McDowell; Joseph R. Drago πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

Adriamycin used in combination with vitamin E (Tocopherol) was evaluated in the treatment of Nb rat prostate adenocarcinoma. Vitamin E has been shown to enhance the growth-inhibitory effects of adriamycin on human prostatic carcinoma cells in vitro. The adriamycin-vitamin E treatment groups had the

Nb rat prostate adenocarcinoma model: Ev
✍ Joseph R. Drago; Jeff Lombard πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 236 KB

During the course of the last 6 years, this laboratory unit has evaluated the Nb rat prostate adenocarcinoma model with respect to various chemotherapies. Heretofore, tumors were treated after they had been implanted in the subcutaneous space. The most active chemotherapeutic agents have been cyclop